Hi, I'm Andrew Ross Sorkin, co-host of Squawk Box, and this is five things to know before today's

opening bell. Mark reportedly in talks about cancer drug maker RevMed for between $28 and $32 billion,

financial time saying a deal is likely several weeks away, but it would be the biggest in the

pharma sector in nearly three years. Yesterday,

AbVee denied a report from the Wall Street Journal that it was in talks to buy RevMed.

Meantime, fitness tracking app Strava confidentially now filing for an IPO. It's according to a

source familiar with the matter who spoke to CNBC. The Wall Street Journal reporting that

the owner of the luxury department store, Sacks, nearing a deal for a bankruptcy financing package of more than a billion dollars.

And Paramount Skydance has now held talks with companies and music industry figures about taking a stake in MTV as it looks to reinvigorate that network.

And that's according to Bloomberg News.

And NASA, saying a serious medical condition with a crew member aboard the International Space Station will prompt an early return for the astronaut and three other crew members. It's unclear what the condition is or who is affected.

We're going to be back later today with an all-new SquawkPod, our daily podcast, featuring the best of Squackbox. Check it out wherever you get your podcast and listen anytime.